| Feature | Specification |
|---|---|
| Application | Noninvasive Prenatal Testing (NIPT) |
Qualitative assay intended for in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation. Features Model Compatible With Vanadis Core™.
| Application |
Noninvasive Prenatal Testing (NIPT)
|
|---|---|
| Brand |
Vanadis Core™
|
| Disorders |
Common Trisomies
|
| Instrument Compatibility |
Vanadis NIPT System
|
| Regulatory Status |
CE-IVD marked (Notified Body 0537)
|
| Sample Type |
Serum
|
| Technology |
Rolling Circle Amplification (RCA)
|
| Unit Size |
84 samples
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.